Digital Biomarker Scientist (f/m/d)

You will be part of an integrated team of scientists, technologists, data analysts, and operationalization experts who leverage mobile technologies — such as smartphones and wearables — to collect objective, continuous sensor data from patients in clinical trials and clinical care.

They co-create innovative digital biomarker concepts for sensitive and meaningful drug development endpoints, implement them in technology solutions, develop health related outcome measures, seek community- and regulatory acceptance of corresponding endpoints and provide end-to-end services to Biopharma companies and research institutes for the collection and analysis of digital endpoint data in clinical trials. Moreover, they are establishing the scientific foundations for disease monitoring and screening solutions in clinical practice.

This role will focus in particular on digital biomarker solutions for Parkinson’s and Huntington’s disease.

Tasks and responsibilities 

• Provide scientific guidance for data analysis projects
• Support interactions with customers during the pre- and post-sales phases
• Contribute to the communication of scientific results at conferences, in white-papers, and in peer-reviewed publications
• Develop scientific core messages for product marketing

Profile 

• University degree (Ph.D. or equivalent) in Life Sciences or related field
• Minimum of 5 years related experience in the pharmaceutical and digital health industry
• Track record of writing compelling publications in high impact, peer reviewed journals
• Knowledge of disease etiology and symptomatology for Parkinson's and Huntington's disease
• Comprehensive understanding of the current state of drug development for Parkinson's and Huntington's disease
• In-depth knowledge of the clinical endpoint landscape and associated challenges in Parkinson's and Huntington's disease
• Overview of existing digital biomarker approaches for these diseases
• Deep experience in the area of digital biomarker development

Additional beneficial skills 

• Experience working directly with people living with Parkinson’s and Huntington’s disease
• Experience with developing digital biomarkers, digital clinical outcome assessments and digital endpoints
• Experience with FDA/EMA regulatory interactions and participation in regulatory consortia focused on clinical drug development and novel drug development endpoints

General information 

• Start date: as soon as possible (preferably before November 2025)
• Planned duration: 1 year (extension possible)
• Place of work: Basel
• Workload: 100%
• Home office: available upon agreement

If you are interested in this opportunity, please send your CV in English.